Graduate School of Chengde Medical University, Chengde, He Bei Provence, China.
Department of Emergency, Chengde Central Hospital, Chengde, He Bei Provence, China.
PLoS One. 2023 Sep 15;18(9):e0290619. doi: 10.1371/journal.pone.0290619. eCollection 2023.
Neurofilament light chain (NfL) is a novel biomarker for the assessment of neurological function after cardiac arrest (CA). Although meta-analysis has confirmed its predictive value, it has not conducted a more detailed analysis of its research. We conducted a meta-analysis to evaluate the relationship between serum NfL level and neurological prognosis in patients with spontaneous circulation recovery after CA, and subgroup analysis was conducted according to sample collection time, time to assess neurological function, study design, whether TTM was received, the method of specimen determination, and the presence of neurological disease in patients. To analyze the influence of these factors on the predictive value of serum NfL.
Published Cochrane reviews and an updated, extended search of MEDLINE, Cochrane Library, Embase, Scopus, ClinicalKey, CINAHL, and Web of Science for relevant studies until March 2022 were assessed through inclusion and exclusion criteria. The standard mean difference and 95% confidence interval were calculated using the random-effects model or fixed-effects model to assess the association between one variable factor NfL level and the outcome of CA patients. Subgroup analysis according to sample collection time was performed. The prognosis analysis and publication bias were also assessed using Egger's and Begg's tests.
Among 1209 related articles for screening, 6 studies (1360 patients) met the inclusion criteria and were selected for meta-analysis. The level of serum NfL in the good prognosis group (CPC1-2, CPC: cerebral performance category score) was significantly lower than that in the poor prognosis group (CPC3-5)SMD(standardized mean difference) = 0.553, 95%CI(confidence interval) = 0.418-0.687, I2 = 65.5% P<0.05). And this relationship also exists at each sampling time point (NfL specimens were collected on admission: SMD:0.48,95%CI:0.24-0.73; Samples were collected 24 hours after CA: SMD:0.60,95%CI:0.32-0.88;Specimens were obtained 48 hours after CA: SMD:0.51, 95%CI:0.18-0.85;Specimens were obtained 72 hours after CA: SMD:0.59, 95%CI:0.38-0.81).
NfL may play a potential neuroprognostication role in postcardiac arrest patients with spontaneous circulation, regardless of when the sample was collected after CA.
神经丝轻链(NfL)是评估心脏骤停(CA)后神经功能的新型生物标志物。虽然荟萃分析已经证实了其预测价值,但尚未对其研究进行更详细的分析。我们进行了一项荟萃分析,以评估血清 NfL 水平与 CA 后自主循环恢复患者的神经预后之间的关系,并根据样本采集时间、评估神经功能的时间、研究设计、是否接受 TTM、标本测定方法以及患者是否存在神经疾病进行亚组分析。分析这些因素对血清 NfL 预测价值的影响。
通过纳入和排除标准,评估了发表的 Cochrane 综述以及对 MEDLINE、Cochrane 图书馆、Embase、Scopus、ClinicalKey、CINAHL 和 Web of Science 进行的更新和扩展搜索,以评估相关研究。使用随机效应模型或固定效应模型计算标准均数差值和 95%置信区间,以评估单变量因素 NfL 水平与 CA 患者结局之间的关系。根据样本采集时间进行了亚组分析。还使用 Egger 和 Begg 检验进行预后分析和发表偏倚评估。
在筛选的 1209 篇相关文章中,有 6 项研究(1360 名患者)符合纳入标准并被纳入荟萃分析。预后良好组(CPC1-2,CPC:脑功能分类评分)的血清 NfL 水平明显低于预后不良组(CPC3-5)SMD(标准化均数差)=0.553,95%CI(置信区间)=0.418-0.687,I2=65.5%P<0.05)。而且这种关系在每个采样时间点都存在(入院时采集 NfL 标本:SMD:0.48,95%CI:0.24-0.73;CA 后 24 小时采集样本:SMD:0.60,95%CI:0.32-0.88;CA 后 48 小时采集样本:SMD:0.51,95%CI:0.18-0.85;CA 后 72 小时采集样本:SMD:0.59,95%CI:0.38-0.81)。
NfL 可能在心脏骤停后自主循环恢复的患者中发挥潜在的神经预后作用,无论 CA 后何时采集样本。